- Home
- AQST vs TRVG Comparison
AQST vs TRVG Comparison
Compare AQST & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- TRVG
- Stock Information
- Founded
- AQST 2004
- TRVG 2005
- Country
- AQST United States
- TRVG Germany
- Employees
- AQST N/A
- TRVG N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- TRVG EDP Services
- Sector
- AQST Health Care
- TRVG Technology
- Exchange
- AQST Nasdaq
- TRVG Nasdaq
- Market Cap
- AQST 274.4M
- TRVG 306.5M
- IPO Year
- AQST 2018
- TRVG N/A
- Fundamental
- Price
- AQST $3.02
- TRVG $4.73
- Analyst Decision
- AQST Strong Buy
- TRVG Hold
- Analyst Count
- AQST 7
- TRVG 5
- Target Price
- AQST $10.57
- TRVG $2.94
- AVG Volume (30 Days)
- AQST 1.3M
- TRVG 119.6K
- Earning Date
- AQST 03-05-2025
- TRVG 04-29-2025
- Dividend Yield
- AQST N/A
- TRVG N/A
- EPS Growth
- AQST N/A
- TRVG N/A
- EPS
- AQST N/A
- TRVG N/A
- Revenue
- AQST $57,561,000.00
- TRVG $477,118,749.00
- Revenue This Year
- AQST N/A
- TRVG $9.85
- Revenue Next Year
- AQST $35.72
- TRVG $6.77
- P/E Ratio
- AQST N/A
- TRVG N/A
- Revenue Growth
- AQST 13.79
- TRVG N/A
- 52 Week Low
- AQST $2.24
- TRVG $1.60
- 52 Week High
- AQST $5.80
- TRVG $5.45
- Technical
- Relative Strength Index (RSI)
- AQST 50.92
- TRVG 55.76
- Support Level
- AQST $3.05
- TRVG $4.63
- Resistance Level
- AQST $3.24
- TRVG $5.45
- Average True Range (ATR)
- AQST 0.20
- TRVG 0.39
- MACD
- AQST 0.04
- TRVG 0.01
- Stochastic Oscillator
- AQST 57.47
- TRVG 53.46
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About TRVG trivago N.V.
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.